Skip to main content
PhiChem Corporation logo

PhiChem Corporation — Investor Relations & Filings

Ticker · 300398 ISIN · CNE100001XV1 Shenzhen Stock Exchange Manufacturing
Filings indexed 2,231 across all filing types
Latest filing 2026-05-25 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300398

About PhiChem Corporation

https://www.phichem.com.cn

PhiChem Corporation specializes in the research, development, and manufacturing of high-performance materials, with a primary focus on UV-curable products. The company is a leading global supplier of ultraviolet (UV) curable coatings for optical fibers and cables, supporting telecommunications infrastructure. Its product portfolio extends to electronic materials, including photoresists, solder masks, and specialty chemicals used in the fabrication of printed circuit boards (PCBs), integrated circuits, and semiconductor packaging. Additionally, PhiChem provides advanced materials for the display industry, such as liquid crystal materials and functional coatings. By leveraging expertise in polymer chemistry and precision formulation, the company serves diverse high-tech sectors, emphasizing innovation in material science to meet the evolving demands of the global electronics and communications markets.

Recent filings

Filing Released Lang Actions
关于作废2025年限制性股票激励计划部分已授予但尚未归属的限制性股票的公告
Regulatory Filings Classification · 80% confidence The document is a formal corporate announcement under Chinese listing rules describing the cancellation of unvested restricted stock under the 2025 incentive plan. It does not contain financial statements, proxy materials, dividend details, M&A, delisting, or call transcripts. It is not an actual financial report but a regulatory disclosure of a board decision. This falls into the general “Regulatory Filings” category (RNS).
2026-05-25 Chinese
关于公司及控股子公司担保进展的公告
Regulatory Filings Classification · 74% confidence The document is a formal corporate disclosure announcing the progress of guaranty arrangements by the company and its subsidiaries (credit facilities, guarantee contracts, and related financial data). It does not constitute an earnings release, audit, capital issuance, M&A filing, or substantive financial report, nor is it a proxy/material for a shareholder vote. There is no dedicated “guarantee” category, so this announcement falls under general regulatory filings.
2026-05-25 Chinese
关于调整2025年限制性股票激励计划授予价格的公告
Remuneration Information Classification · 72% confidence The document is a formal corporate announcement by Shanghai Feikai Materials Technology Co., Ltd. regarding adjustments to the grant price under its 2025 restricted stock incentive plan. It details board and committee resolutions, legal opinions, adjustment methodology, and the impact on share-based remuneration. This is not a proxy solicitation (PSI) nor a full annual/interim report, but rather a compensation-related disclosure on an equity incentive plan. According to the defined categories, it best fits under Remuneration Information (DEF 14A).
2026-05-25 Chinese
国元证券股份有限公司关于上海飞凯材料科技股份有限公司2025年限制性股票激励计划首次授予第一个归属期归属相关事项之独立财务顾问报告
Regulatory Filings Classification · 35% confidence The document is an Independent Financial Advisor Report (“独立财务顾问报告”) prepared by Guoyuan Securities for Shanghai Feikai Materials’ 2025 restricted stock incentive plan (initial grant, first vesting period). It is a standalone compliance/reporting document required under Chinese securities rules rather than an earnings release, proxy statement, dividend notice, or financial statements. It does not itself propose or vote on matters (so not PSI), nor is it the share issuance announcement itself (so not SHA). It is not a mere announcement of publication (RPA) but the full report. Thus, it falls under the fallback “Regulatory Filings” category (RNS).
2026-05-25 Chinese
董事会薪酬与考核委员会关于2025年限制性股票激励计划相关事项的核查意见
Share Issue/Capital Change Classification · 70% confidence The document is a formal committee opinion by the board’s remuneration and assessment committee regarding the first vesting, price adjustment, and cancellation of shares under the company’s 2025 restricted stock incentive plan. It details issuing 3,086,800 restricted shares and canceling 61,000 shares, which constitutes a capital change through share issuance and cancellation. Therefore, it best fits the Share Issue/Capital Change category (SHA).
2026-05-25 Chinese
第六届董事会第二次会议决议公告
Regulatory Filings Classification · 80% confidence The document is an announcement of board of directors meeting resolutions (第六届董事会第二次会议决议公告) regarding restricted stock incentive plans—vesting, price adjustment, and cancellations. It is not a shareholder meeting vote result, not an earnings release, not a report publication notice, nor management change. It is a corporate announcement of board resolutions, which does not fit any more specific category, so it falls under the fallback “Regulatory Filings” (RNS).
2026-05-25 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.